Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53,450 | 12 | 59.3% |
| Consulting Fee | $19,924 | 5 | 22.1% |
| Food and Beverage | $10,920 | 185 | 12.1% |
| Travel and Lodging | $5,716 | 10 | 6.3% |
| Education | $165.39 | 13 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $69,504 | 128 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $14,722 | 7 | $0 (2024) |
| Allergan, Inc. | $1,009 | 13 | $0 (2022) |
| Dermavant Sciences, Inc. | $998.15 | 13 | $0 (2024) |
| GENZYME CORPORATION | $589.54 | 8 | $0 (2024) |
| Galderma Laboratories, L.P. | $562.10 | 10 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $533.63 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $367.10 | 8 | $0 (2024) |
| Biofrontera Inc. | $330.07 | 2 | $0 (2023) |
| Amgen Inc. | $301.72 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57,863 | 90 | ABBVIE INC. ($41,277) |
| 2023 | $26,863 | 62 | AbbVie Inc. ($26,045) |
| 2022 | $2,647 | 29 | ABBVIE INC. ($1,229) |
| 2021 | $491.40 | 16 | Allergan, Inc. ($215.45) |
| 2020 | $350.45 | 8 | GENZYME CORPORATION ($126.08) |
| 2019 | $772.74 | 8 | AbbVie, Inc. ($236.15) |
| 2018 | $1,088 | 11 | AbbVie, Inc. ($621.00) |
| 2017 | $99.75 | 1 | GENZYME CORPORATION ($99.75) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $74.90 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $61.21 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/10/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $110.09 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $122.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $21.59 | General |
| 10/26/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $176.89 | General |
| Category: DERMATOLOGY | ||||||
| 10/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $168.88 | General |
| 10/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $113.14 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $48.46 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $135.68 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,500.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 429 | 621 | $147,111 | $27,407 |
| 2022 | 10 | 593 | 893 | $202,128 | $34,086 |
| 2021 | 6 | 248 | 364 | $69,551 | $15,445 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 185 | $54,945 | $10,732 | 19.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 67 | 79 | $29,862 | $5,421 | 18.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 80 | 97 | $21,631 | $3,439 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 24 | $10,080 | $2,327 | 23.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 32 | 34 | $11,492 | $2,138 | 18.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $11,070 | $1,859 | 16.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 25 | $4,650 | $782.82 | 16.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 44 | 147 | $3,381 | $708.48 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 187 | $55,165 | $10,716 | 19.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 94 | 128 | $47,872 | $8,882 | 18.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 97 | 97 | $35,405 | $4,570 | 12.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 91 | 113 | $24,973 | $3,235 | 13.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 47 | 51 | $17,238 | $2,819 | 16.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 35 | 38 | $6,992 | $1,280 | 18.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 53 | 225 | $5,175 | $1,100 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $5,408 | $937.07 | 17.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 15 | 18 | $3,348 | $530.32 | 15.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 13 | 23 | $552.00 | $15.56 | 2.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 70 | $20,440 | $4,805 | 23.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 50 | 50 | $18,300 | $4,326 | 23.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $10,411 | $2,513 | 24.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 45 | 45 | $9,585 | $1,662 | 17.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 23 | 23 | $7,728 | $1,390 | 18.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 32 | 147 | $3,087 | $749.11 | 24.3% |
About Dr. Jacqueline Watchmaker, M.D
Dr. Jacqueline Watchmaker, M.D is a Internal Medicine healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1033568761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacqueline Watchmaker, M.D has received a total of $90,176 in payments from pharmaceutical and medical device companies, with $57,863 received in 2024. These payments were reported across 225 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($53,450).
As a Medicare-enrolled provider, Watchmaker has provided services to 1,270 Medicare beneficiaries, totaling 1,878 services with total Medicare billing of $76,938. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology
- Location Scottsdale, AZ
- Active Since 06/03/2016
- Last Updated 08/31/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033568761
Products in Payments
- BOTOX (Biological) $40,023
- VTAMA (Drug) $998.15
- YCANTH (Drug) $533.63
- Humira (Biological) $523.00
- Otezla (Drug) $409.34
- AMELUZ (Drug) $330.07
- DUPIXENT (Biological) $292.73
- TREMFYA (Drug) $248.62
- TALTZ (Drug) $233.01
- DUPIXENT (Drug) $124.99
- Skyrizi (Biological) $120.45
- Tremfya (Drug) $118.48
- Apligraf (Biological) $105.63
- ATOPIC DERMATITIS - DISEASE (Drug) $99.75
- SKYRIZI (Biological) $97.01
- Apligraf (Device) $82.46
- DAXXIFY (Drug) $80.94
- TWYNEO (Drug) $80.04
- DUOBRII (Drug) $74.27
- Xeomin (Biological) $62.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Scottsdale
Dr. Christina Ha, M.d, M.D
Internal Medicine — Payments: $257,547
Bassam Abu Jawdeh, Md, MD
Internal Medicine — Payments: $175,490
Dr. Thai Ho, M.d./Ph.d, M.D./PH.D
Internal Medicine — Payments: $129,128
Craig Primack, Md, MD
Internal Medicine — Payments: $107,435
Dr. Amar Thosani, M.d, M.D
Internal Medicine — Payments: $71,283
Dr. Victoria Horstman, Md, MD
Internal Medicine — Payments: $62,353